These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 20569725)

  • 21. Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update.
    Tsuji Y; Dobrev D
    Vasc Health Risk Manag; 2013; 9():165-75. PubMed ID: 23637539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological cardioversion of atrial fibrillation with vernakalant: evidence in support of the ESC Guidelines.
    Savelieva I; Graydon R; Camm AJ
    Europace; 2014 Feb; 16(2):162-73. PubMed ID: 24108230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and Safety of Vernakalant for Cardioversion of Recent-onset Atrial Fibrillation in the Asia-Pacific Region: A Phase 3 Randomized Controlled Trial.
    Beatch GN; Bhirangi K; Juul-Moller S; Rustige J
    J Cardiovasc Pharmacol; 2017 Feb; 69(2):86-92. PubMed ID: 27828791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population pharmacokinetic-pharmacodynamic analysis of vernakalant hydrochloride injection (RSD1235) in atrial fibrillation or atrial flutter.
    Mao Z; Wheeler JJ; Townsend R; Gao Y; Kshirsagar S; Keirns JJ
    J Pharmacokinet Pharmacodyn; 2011 Oct; 38(5):541-62. PubMed ID: 21786177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study.
    Cotter G; Blatt A; Kaluski E; Metzkor-Cotter E; Koren M; Litinski I; Simantov R; Moshkovitz Y; Zaidenstein R; Peleg E; Vered Z; Golik A
    Eur Heart J; 1999 Dec; 20(24):1833-42. PubMed ID: 10581142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vernakalant for Rapid Cardioversion of Recent-Onset Atrial Fibrillation: Results from the SPECTRUM Study.
    Lévy S; Hartikainen J; Ritz B; Juhlin T; Carbajosa-Dalmau J; Domanovits H
    Cardiovasc Drugs Ther; 2021 Apr; 35(2):283-292. PubMed ID: 33206300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vernakalant: Perception of state of health in patients with a recent-onset atrial fibrillation.
    Conde D; Costabel JP; Aragon M; Lambardi F; Trivi M
    Cardiol J; 2014; 21(3):304-8. PubMed ID: 23990184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid conversion of persistent atrial fibrillation to sinus rhythm by intravenous AZD7009.
    Geller JC; Egstrup K; Kulakowski P; Rosenqvist M; Jansson MA; Berggren A; Edvardsson N; Sager P; Crijns HJ
    J Clin Pharmacol; 2009 Mar; 49(3):312-22. PubMed ID: 19129422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vernakalant. Too dangerous in atrial fibrillation.
    Prescrire Int; 2012 May; 21(127):119-22. PubMed ID: 22827000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vernakalant: A novel agent for the termination of atrial fibrillation.
    Finnin M
    Am J Health Syst Pharm; 2010 Jul; 67(14):1157-64. PubMed ID: 20592320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic Review and Meta-analysis Appraising Efficacy and Safety of Vernakalant for Cardioversion of Recent-Onset Atrial Fibrillation.
    Ma W; Guo X; Wang Q; Sun G; Wang J
    J Cardiovasc Pharmacol; 2020 Jul; 76(1):32-41. PubMed ID: 32251022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of vernakalant in patients with atrial flutter: a randomized, double-blind, placebo-controlled trial.
    Camm AJ; Toft E; Torp-Pedersen C; Vijayaraman P; Juul-Moller S; Ip J; Beatch GN; Dickinson G; Wyse DG;
    Europace; 2012 Jun; 14(6):804-9. PubMed ID: 22291438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is vernakalant better or not, compared with other treatments for conversion of acute atrial fibrillation?
    Conde D
    Int J Cardiol; 2013 Oct; 169(2):95-6. PubMed ID: 24071384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ibutilide to expedite ED therapy for recent-onset atrial fibrillation flutter.
    Mountantonakis SE; Moutzouris DA; Tiu RV; Papaioannou GN; McPherson CA
    Am J Emerg Med; 2006 Jul; 24(4):407-12. PubMed ID: 16787796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rhythm-independent feature of heart rate dynamics common to atrial fibrillation and sinus rhythm in patients with paroxysmal atrial fibrillation.
    Sato K; Yamasaki F; Furuno T; Hamada T; Mukai S; Hayano J; Sugiura T; Doi Y
    J Cardiol; 2003 Dec; 42(6):269-76. PubMed ID: 14723019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of sequential antiarrhythmic treatment in sinus rhythm maintenance after successful electrocardioversion in patients with chronic non-valvular atrial fibrillation.
    Kosior D; Opolski G; Torbicki A
    Med Sci Monit; 2001; 7(1):68-73. PubMed ID: 11208496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population pharmacokinetics of vernakalant hydrochloride injection (RSD1235) in patients with atrial fibrillation or atrial flutter.
    Mao ZL; Townsend RW; Gao Y; Wheeler JJ; Kastrissios H; Keirns J
    J Clin Pharmacol; 2012 Jul; 52(7):1042-53. PubMed ID: 21659624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of pharmacological cardioversion of atrial fibrillation using intravenous vernakalant, a new antiarrhythmic drug with atrial selectivity.
    Blomström-Lundqvist C; Blomström P
    Expert Opin Drug Saf; 2012 Jul; 11(4):671-9. PubMed ID: 22632377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safe and effective conversion of persistent atrial fibrillation to sinus rhythm by intravenous AZD7009.
    Crijns HJ; Van Gelder IC; Walfridsson H; Kulakowski P; Rónaszéki A; Dedek V; Malm A; Almgren O
    Heart Rhythm; 2006 Nov; 3(11):1321-31. PubMed ID: 17074639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy of intravenous and per os propafenone in the ambulatory treatment of recent-onset atrial fibrillation].
    Margheri M; Fradella G; Maioli M; Paterni M; Bartoli P; Bonechi F; Brandinelli A; Mazza F; Sansoni M; Zipoli A
    G Ital Cardiol; 1992 Mar; 22(3):257-65. PubMed ID: 1426770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.